Medy-Tox Inc. (KOSDAQ: 086900)
South Korea
· Delayed Price · Currency is KRW 124,000
-900 (-0.72%)
Dec 20, 2024, 9:00 AM KST
Medy-Tox Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 241,450 | 221,121 | 195,096 | 184,870 | 140,828 | 205,900 | Upgrade
|
| Other Revenue | - | - | -0 | -0 | - | - | Upgrade
|
| Revenue | 241,450 | 221,121 | 195,096 | 184,870 | 140,828 | 205,900 | Upgrade
|
| Revenue Growth (YoY) | 17.56% | 13.34% | 5.53% | 31.27% | -31.60% | 0.22% | Upgrade
|
| Cost of Revenue | 96,585 | 87,625 | 69,048 | 79,397 | 66,928 | 70,044 | Upgrade
|
| Gross Profit | 144,865 | 133,496 | 126,048 | 105,473 | 73,900 | 135,856 | Upgrade
|
| Selling, General & Admin | 93,465 | 86,605 | 47,679 | 41,938 | 59,544 | 67,725 | Upgrade
|
| Research & Development | 25,133 | 25,133 | 23,324 | 23,267 | 32,544 | 27,016 | Upgrade
|
| Other Operating Expenses | 1,322 | 1,322 | 1,242 | 1,216 | 1,403 | 1,225 | Upgrade
|
| Operating Expenses | 123,034 | 116,173 | 79,383 | 72,335 | 110,969 | 110,167 | Upgrade
|
| Operating Income | 21,832 | 17,322 | 46,665 | 33,138 | -37,070 | 25,689 | Upgrade
|
| Interest Expense | -2,333 | -2,333 | -2,314 | -4,781 | -4,176 | -2,081 | Upgrade
|
| Interest & Investment Income | 896.43 | 896.43 | 610.76 | 957.22 | 340.02 | 338.87 | Upgrade
|
| Earnings From Equity Investments | 2,171 | 1,363 | 5,129 | -1,456 | -2,432 | 2,371 | Upgrade
|
| Currency Exchange Gain (Loss) | 475.22 | 475.22 | 3,425 | 2,111 | -376.81 | 1,408 | Upgrade
|
| Other Non Operating Income (Expenses) | -8,343 | -605.87 | -715.84 | 108,431 | 6,967 | -1,273 | Upgrade
|
| EBT Excluding Unusual Items | 14,698 | 17,118 | 52,800 | 138,400 | -36,748 | 26,453 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -711.12 | -2,460 | Upgrade
|
| Gain (Loss) on Sale of Investments | -593.36 | -593.36 | -3,044 | 2,666 | -1,067 | 2,231 | Upgrade
|
| Gain (Loss) on Sale of Assets | -671.97 | -671.97 | -230.42 | 131.48 | 58.63 | -760.43 | Upgrade
|
| Asset Writedown | - | - | - | -12,932 | -3,671 | -313.35 | Upgrade
|
| Pretax Income | 13,433 | 15,853 | 49,526 | 128,265 | -42,139 | 25,150 | Upgrade
|
| Income Tax Expense | 1,933 | 6,163 | 12,930 | 35,003 | -12,100 | -413.11 | Upgrade
|
| Earnings From Continuing Operations | 11,500 | 9,690 | 36,596 | 93,263 | -30,039 | 25,563 | Upgrade
|
| Minority Interest in Earnings | 201.92 | 65.28 | 414.16 | 891.27 | 462.11 | 642.52 | Upgrade
|
| Net Income | 11,702 | 9,755 | 37,010 | 94,154 | -29,577 | 26,206 | Upgrade
|
| Preferred Dividends & Other Adjustments | 975 | 975 | 975.33 | 974.73 | 0.7 | - | Upgrade
|
| Net Income to Common | 10,727 | 8,780 | 36,035 | 93,179 | -29,577 | 26,206 | Upgrade
|
| Net Income Growth | 3.36% | -73.64% | -60.69% | - | - | -62.54% | Upgrade
|
| Shares Outstanding (Basic) | 7 | 7 | 7 | 6 | 6 | 6 | Upgrade
|
| Shares Outstanding (Diluted) | 7 | 7 | 7 | 6 | 6 | 6 | Upgrade
|
| Shares Change (YoY) | -9.89% | 2.02% | 2.28% | 0.04% | -0.82% | 2.75% | Upgrade
|
| EPS (Basic) | 1609.25 | 1311.06 | 5491.68 | 14587.59 | -4609.95 | 4050.83 | Upgrade
|
| EPS (Diluted) | 1609.18 | 1311.00 | 5489.34 | 14517.37 | -4610.30 | 4050.83 | Upgrade
|
| EPS Growth | 15.06% | -76.12% | -62.19% | - | - | -63.55% | Upgrade
|
| Free Cash Flow | 11,641 | 5,862 | 16,304 | 2,452 | -13,217 | 12,682 | Upgrade
|
| Free Cash Flow Per Share | 1746.30 | 875.31 | 2483.65 | 382.01 | -2059.99 | 1960.41 | Upgrade
|
| Dividend Per Share | 2200.000 | 1100.000 | - | - | - | - | Upgrade
|
| Gross Margin | 60.00% | 60.37% | 64.61% | 57.05% | 52.48% | 65.98% | Upgrade
|
| Operating Margin | 9.04% | 7.83% | 23.92% | 17.93% | -26.32% | 12.48% | Upgrade
|
| Profit Margin | 4.44% | 3.97% | 18.47% | 50.40% | -21.00% | 12.73% | Upgrade
|
| Free Cash Flow Margin | 4.82% | 2.65% | 8.36% | 1.33% | -9.39% | 6.16% | Upgrade
|
| EBITDA | 41,347 | 32,698 | 61,766 | 51,394 | -18,472 | 43,830 | Upgrade
|
| EBITDA Margin | 17.12% | 14.79% | 31.66% | 27.80% | -13.12% | 21.29% | Upgrade
|
| D&A For EBITDA | 19,516 | 15,376 | 15,101 | 18,256 | 18,597 | 18,141 | Upgrade
|
| EBIT | 21,832 | 17,322 | 46,665 | 33,138 | -37,070 | 25,689 | Upgrade
|
| EBIT Margin | 9.04% | 7.83% | 23.92% | 17.93% | -26.32% | 12.48% | Upgrade
|
| Effective Tax Rate | 14.39% | 38.88% | 26.11% | 27.29% | - | - | Upgrade
|
| Advertising Expenses | - | 5,976 | 3,351 | 2,031 | 3,839 | 8,228 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.